Does CRESTOR Cause Therapy cessation? 11 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Therapy cessation have been filed in association with CRESTOR. This represents 0.9% of all adverse event reports for CRESTOR.
11
Reports of Therapy cessation with CRESTOR
0.9%
of all CRESTOR reports
0
Deaths
3
Hospitalizations
How Dangerous Is Therapy cessation From CRESTOR?
Of the 11 reports, 3 (27.3%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CRESTOR. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does CRESTOR Cause?
Type 2 diabetes mellitus (342)
Cardiovascular disorder (319)
Myocardial infarction (135)
Myalgia (87)
Drug dose omission (83)
Blood cholesterol increased (75)
Off label use (60)
Drug hypersensitivity (51)
Intentional product misuse (49)
Drug ineffective (48)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which CRESTOR Alternatives Have Lower Therapy cessation Risk?
CRESTOR vs CRISABOROLE
CRESTOR vs CRIZANLIZUMAB
CRESTOR vs CRIZANLIZUMAB-TMCA
CRESTOR vs CRIZOTINIB
CRESTOR vs CROFELEMER